Application advance on screening of anti-cancer drugs in the early stage of pharmacokinetics based on 3D cell culture model

鲁萌,周芳,刘嘉莉,贾元威,倪苹,王广基,张经纬
2017-01-01
Abstract:Despite significant improvements in ways to treat cancer,numerous patients still die from it.One of the important reasons for this problem is that high failure of clinical transformation ratio due largely to poor PK/PD behavior.As time moves on,many new data increasingly reveal that traditional pharmacokinetics study in vivo cannot totally explain the efficacy of drug targeting on the intra-cell.Previously 2D cell culture has been the most popular in vivo models in drug screening and R&D.However,2D cell culture techniques do not faithfully replicate all of the mechanical and biochemical signals present in vivo.It is necessary to improve the early drug developmental stage to evaluate new drugs or drug combinations.3D cell culture systems can reproduce the characteristics of solid tumors in vivo vividly.Growing cells such as 3D models used in cellular pharmacokinetics break a new through on cell based assay and evaluation of anti-cancer drugs.This review aims first to shortly report on 3D culture systems currently and second to introduce the applications and advantages of cellular pharmacokinetics evaluation of anti-cancer drugs based on 3 D cell model.
What problem does this paper attempt to address?